Propriedade e atividade de insiders de Alkermes plc (ALKS): operações de insiders, negociações do Senado e da Câmara dos EUA e ações em circulação. Acompanhe como executivos e políticos negociam a ação.
Preço
| Preço | $46.07 |
| Capitalização | $7.7B |
| Bolsa | NASDAQ |
| País | IE |
Operações Recentes de Insiders
| Data | Insider | Tipo | Ações | Valor |
|---|---|---|---|---|
| 2026-09-03 | Gaffin David Joseph | S-Sale | 2,034 | $98K |
| 2026-09-01 | Hopkinson Craig C. | M-Exempt | 5,000 | $123K |
| 2026-09-01 | Hopkinson Craig C. | S-Sale | 9,000 | $423K |
| 2026-09-01 | Hopkinson Craig C. | M-Exempt | 5,000 | $123K |
| 2026-08-17 | Nichols Christian Todd | S-Sale | 6,912 | $340K |
| 2026-08-17 | Nichols Christian Todd | S-Sale | 664 | $33K |
| 2026-08-05 | Jackson Blair Curtis | A-Award | 124,305 | $6.2M |
| 2026-08-05 | Jackson Blair Curtis | A-Award | 93,229 | $4.6M |
| 2026-08-03 | snyderman nancy lynn MD | M-Exempt | 16,524 | $772K |
| 2026-08-03 | snyderman nancy lynn MD | M-Exempt | 27,948 | $1.3M |
Balanço (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caixa e Equivalentes | $186.4M | $191.3M | $266.8M | $203.8M | $273.0M | $337.5M | $292.5M | $457.5M | $291.1M | $1.12B |
| Investimentos de Curto Prazo | $310.9M | $242.2M | $272.5M | $331.2M | $362.1M | $198.8M | $316.0M | $316.0M | $460.5M | $199.6M |
| Contas a Receber | $191.1M | $233.6M | $300.5M | $265.5M | $289.5M | $326.6M | $296.9M | $333.2M | $389.5M | $334.0M |
| Estoque | $63.0M | $93.3M | $90.2M | $101.8M | $125.7M | $150.3M | $181.4M | $186.4M | $182.9M | $196.6M |
| Ativos Circulantes | $912.6M | $966.1M | $983.3M | $962.0M | $1.11B | $1.06B | $1.13B | $1.49B | $1.42B | $1.93B |
| Imobilizado | $264.8M | $284.7M | $310.0M | $374.5M | $481.7M | $456.7M | $320.5M | $318.4M | $311.8M | $298.9M |
| Ágio | $92.9M | $92.9M | $92.9M | $92.9M | $92.9M | $92.9M | $83.0M | $83.0M | $83.0M | 0 |
| Ativos Intangíveis | $318.2M | $256.2M | $191.0M | $150.6M | $111.2M | $74.0M | $37.7M | $2.0M | $890000 | $83.8M |
| Ativos Totais | $1.73B | $1.80B | $1.83B | $1.81B | $1.95B | $2.02B | $1.96B | $2.14B | $2.06B | $2.53B |
| Contas a Pagar | $46.3M | $55.5M | $39.8M | $54.3M | $46.0M | $55.7M | $32.8M | $65.6M | $45.6M | $108.0M |
| Dívida de Curto Prazo | $3.0M | $3.0M | $2.8M | $2.8M | $2.8M | $3.0M | $3.0M | $3.0M | 0 | $6.7M |
| Passivos Circulantes | $212.0M | $291.1M | $339.8M | $391.1M | $438.3M | $471.3M | $497.7M | $520.2M | $465.2M | $543.4M |
| Dívida de Longo Prazo | $280.7M | $278.4M | $276.5M | $274.3M | $272.1M | $292.8M | $290.3M | $287.7M | 0 | 0 |
| Passivos Totais | $516.9M | $594.4M | $653.7M | $720.0M | $882.7M | $911.9M | $920.2M | $933.5M | $590.6M | $711.0M |
| Reservas | -$947.9M | -$1.04B | -$1.19B | -$1.38B | -$1.49B | -$1.54B | -$1.70B | -$1.34B | -$976.5M | -$734.8M |
| Patrimônio Líquido | $1.21B | $1.20B | $1.17B | $1.09B | $1.07B | $1.11B | $1.04B | $1.20B | $1.46B | $1.82B |
| Dívida Total | $283.7M | $281.4M | $279.3M | $290.9M | $410.2M | $416.2M | $379.4M | $372.2M | $75.5M | $70.0M |
| Dívida Líquida | -$335.5M | -$309.3M | -$260.0M | -$244.0M | -$224.9M | -$120.1M | -$229.0M | -$401.3M | -$676.1M | -$1.25B |
| Capital de Giro | $700.6M | $674.9M | $643.5M | $570.9M | $672.7M | $590.9M | $632.6M | $965.3M | $950.2M | $1.39B |
Saúde financeira
| Dívida / Patrimônio | 0.87 |
| Liquidez corrente | 2.30 |
Rentabilidade
| Margem bruta | 84.56% |
| Margem operacional | 7.03% |
| Margem líquida | 3.97% |
Empresas relacionadas: ACAD · ACLX · AKRO · ARWR · CRSP · KYMR · PCVX
Explorar setor: Healthcare · Drug Manufacturers - Specialty & Generic
Mais seções de ALKS: Resumo · Financeiros · Avaliação · Estatísticas · Estimativas · Técnico · Notícias · Eventos
Descubra mais: Radar — sinais de ações subvalorizadas · Academia de Investimento — aprenda a analisar ações